Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05730088

Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home

Led by Necmettin Erbakan University · Updated on 2024-11-22

74

Participants Needed

1

Research Sites

97 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.

CONDITIONS

Official Title

Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with stage 4 (group D) COPD according to GOLD criteria
  • Aged 18 years or older
  • Owns a video computer, tablet, or phone
  • Has internet access at home or on the phone
  • Lives in the city centre of Konya
  • No communication problems preventing participation, such as inability to understand or speak Turkish
  • Literate
  • Uses an oxygen concentrator at home
Not Eligible

You will not qualify if you...

  • Illiterate
  • Diagnosed with stage 1, 2, or 3 COPD according to GOLD criteria
  • Has another lung disease besides COPD (e.g., lung cancer, asthma)
  • Has physical and/or mental disabilities
  • Visually and/or hearing impaired
  • Communication problems preventing participation, such as inability to understand or speak Turkish
  • Diagnosed with or previously had Covid-19
  • Has a psychiatric disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Selçuk Tıp Fakültesi Hastanesi

Konya, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

H

HASAN BAKIR

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here